Comprehensive Directory of China Distributors for Biopharma Equipment & Suppliers
This report on the "Top 60 Distributors of Bioprocessing Supplies in China" covers major distributors of bioprocessing supplies and equipment in the Peoples Republic of China (PRC). Distributor information includes company ownership, background, management, facility capacity and history.
The Directory is based on in-depth research, using public secondary and primary information research. This on-going project is regularly updated, and is intended to provide in-depth information and insights into the rapidly growing and changing Chinese biologics supplies industry.
HIGHLIGHTS
- Best Practices for finding, evaluating, and managing distributors in China
- China’s Emergence in Global Biopharma Manufacturing: Progress and Trends in Chinese Biopharma distribution
- Services in the distribution management and relevant market research services
- Profile Directory of Top 60 Bioprocessing Distributors in China
- Much more...
BY THE NUMBERS:
- 159 Chinese-owned Equipment Distributors and Suppliers
- Top 60 Distributors highlighted
- 100+ pages 20+ Figures
WHY THIS REPORT:
- Assist Western Manufacturers identify potential China distribution partners
- Avoid pitfalls: how to initiate a business relationship in this huge market
- Learn more about the framework for China distribution
- Learn how to successfully work with China distributors
Table of Contents
Chapter 1: Market Demands for High Quality Equipment & Single Use Systems
Chapter 2: China’s Local Bioprocessing Equipment Competition Landscape
Chapter 3: Distribution of Bioprocessing Products in China
Chapter 4: Building a Relationship: Collaborations Between China Distributors and Western Vendors
Chapter 5: Regulatory Environment and Reforms Impacting China Biologics Manufacturing
Companies Mentioned
- 3SBio
- AlphaMab
- Amoy-Top Biotech (subsidiary of Tonghua Dongbao)
- Anhui Anke Biotechnology
- Beigene
- BeigeneJunshi Pharma/Jiangsu Suzhou
- Benemae Pharmaceutical
- Biotech Pharma
- Boehringer-Ingelheim
- CP Guojian Pharmaceutical
- CSPC Pharma
- Celgene Pharma/Shanghai
- Changchun Hi-Tech #2 BCHT
- Changchun Hi-Tech GeneScience
- Changchun Institute
- Chengdu Institute
- Chia Tai Tianqing
- Four Rings
- GSK/Shenzhen
- Gan & Lee
- Generon
- Genor
- Henglius Pharma (a subsidiary of Fosun Pharma)
- Hengrui Pharma/Lianyungang
- Hengrui Pharma/Suzhou
- Hisun
- Huahai Pharma
- Hualan/Beijing
- Hualan/Xinxiang
- Innovent Bio
- JHL biotech
- Jiangsu Wanbang
- Junshi Pharma/Jiangsu, Suzhou
- Junshi Pharma/Ligang, Shanghai
- Kanghong Pharma
- Kelun Pharma
- Lanzhou Institute
- Lee’s Pharma
- Livzon mAb
- Luye Pharma
- Mabtech holding Ltd
- North China
- Pfizer/Hangzhou
- Qilu Pharma
- SL Pharma/Beijing
- SL Pharma/Quebec
- Sanofi/Shenzhen
- ShangPharma (Chempartner)
- Shanghai Institute
- Shanghai Pharma
- Shanghai United Cell/Shanghai
- Simcere Pharma/Jiangsu, Changzhou
- Simcere Pharma/Yantai
- SinoCellTech
- Sinobioway/Tianjin
- Sinovac/Beijing
- Tasly
- Teruisipharm
- Tiantan Biologics
- Tonghua DongBao
- Tot Pharma
- Tri-Prime Gene
- Walvax/Kunming
- Walvax/Taizhou
- Walvax/Yuxi
- Wuhan Institute
- Wuxi Biologics
- Yantai Rongchang (MABPLEX,subsidiary of Yantai Rongchang )
- Zesun Pharma
- Zhuhai Essex
